Somaiya Mayur Ian — SEC Form 4 filings
SEC reporting owner CIK 1760303. 5 Form 4 filings on record with FilingPulse; latest filed 2026-01-22.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2025-01-06 to 2026-01-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 10 legs across 3 filings — 167,001 shares, $3,430,791 total (shares × price as filed on priced legs).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 39,712 shares @ $31.78 ($1,262,047) in NewAmsterdam Pharma Co N.V., filed 2026-01-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | Chief Financial Officer | 5 | — | 10 legs · 167,001 sh · $3,430,791 | 12 |
Form 4 filings — Somaiya Mayur Ian
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-22 | 4 | NewAmsterdam Pharma Co N.V. (NAMS) | Option exercise (M): 60,216 @ $9.26 · Sale (S): 900 @ $30.64 · Sale (S): 39,712 @ $31.78 · Sale (S): 19,604 @ $32.38 · Option exercise (M): 39,784 @ $9.26 · Sale (S): 15,422 @ $33.25 · +3 more | EDGAR |
| 2026-01-07 | 4 | NewAmsterdam Pharma Co N.V. (NAMS) | Sale (S): 5,118 @ $33.25 · Grant/award (A): 25,500 · Grant/award (A): 115,000 (derivative) @ $0 | EDGAR |
| 2025-01-29 | 4 | NewAmsterdam Pharma Co N.V. (NAMS) | Option exercise (M): 46,983 @ $9.26 · Sale (S): 33,679 · Sale (S): 13,304 · Option exercise (M): 14,900 @ $9.26 · Sale (S): 11,495 · Sale (S): 3,405 · +2 more | EDGAR |
| 2025-01-07 | 4 | NewAmsterdam Pharma Co N.V. (NAMS) | Grant/award (A): 38,000 | EDGAR |
| 2025-01-06 | 4 | NewAmsterdam Pharma Co N.V. (NAMS) | Grant/award (A): 220,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1760303 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →